
BIOMEDCENTRAL . COM {
}
Title[redir]:
Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways | BMC Cancer | Peer Review
Description:
Obesity is a global phenomenon and is associated with various types of cancer, including colon cancer. There is a growing interest for safe and effective bioactive compounds that suppress the risk for obesity-promoted colon cancer. Resveratrol (trans-3, 4
Matching Content Categories {π}
- Social Networks
- Technology & Computing
- Non-Profit & Charity
Content Management System {π}
What CMS is biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of biomedcentral.com audience?
π Good Traffic: 50k - 100k visitors per month
Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Biomedcentral.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Biomedcentral.com Make? {π°}
Display Ads {π―}
$690 per month
Our estimates place Biomedcentral.com's monthly online earnings from display ads at $462 to $1,271.
Keywords {π}
bmc, cookies, version, privacy, manuscript, submitted, author, page, data, information, cancer, submission, resubmission, article, optional, content, personal, parties, policy, manage, published, peer, review, original, reviewed, reviewer, report, randall, holcombe, mar, responded, comments, jairam, vanamala, contact, enquiries, editing, authors, choice, essential, make, site, function, advertising, personalisation, usage, analysis, social, media, accepting,
Topics {βοΈ}
authors scientific editing privacy choices/manage cookies igf-1r/wnt bmc european economic area state privacy rights accepting optional cookies peer review 1471-2407 contact manage preferences article published submission enquiries author responded personal data optional cookies data protection essential cookies cookies skip cookies policy privacy policy privacy statement usage analysis social media varying standards elevates apoptosis editorially accepted general enquiries preference centre springer nature content choices privacy published choice make site function advertising personalisation consent processing parties information change accept suppression activation submitted reviewed find
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways
description:Obesity is a global phenomenon and is associated with various types of cancer, including colon cancer. There is a growing interest for safe and effective bioactive compounds that suppress the risk for obesity-promoted colon cancer. Resveratrol (trans-3, 4', 5,-trihydroxystilbene), a stilbenoid found in the skin of red grapes and peanuts suppresses many types of cancers by regulating cell proliferation and apoptosis through a variety of mechanisms, however, resveratrol effects on obesity-promoted colon cancer are not clearly established. We investigated the anti-proliferative effects of resveratrol on HT-29 and SW480 human colon cancer cells in the presence and absence of insulin like growth factor-1 (IGF-1; elevated during obesity) and elucidated the mechanisms of action using IGF-1R siRNA in HT-29 cells which represents advanced colon carcinogenesis. Resveratrol (100-150 ΞΌM) exhibited anti-proliferative properties in HT-29 cells even after IGF-1 exposure by arresting G0/G1-S phase cell cycle progression through p27 stimulation and cyclin D1 suppression. Treatment with resveratrol suppressed IGF-1R protein levels and concurrently attenuated the downstream Akt/Wnt signaling pathways that play a critical role in cell proliferation. Targeted suppression of IGF-1R using IGF-1R siRNA also affected these signaling pathways in a similar manner. Resveratrol treatment induced apoptosis by activating tumor suppressor p53 protein, whereas IGF-1R siRNA treatment did not affect apoptosis. Our data suggests that resveratrol not only suppresses cell proliferation by inhibiting IGF-1R and its downstream signaling pathways similar to that of IGF-1R siRNA but also enhances apoptosis via activation of the p53 pathway. For the first time, we report that resveratrol suppresses colon cancer cell proliferation and elevates apoptosis even in the presence of IGF-1 via suppression of IGF-1R/Akt/Wnt signaling pathways and activation of p53, suggesting its potential role as a chemotherapeutic agent.
datePublished:2010-05-26T00:00:00Z
dateModified:2010-05-26T00:00:00Z
pageStart:1
pageEnd:14
license:http://creativecommons.org/licenses/by/2.0
sameAs:https://doi.org/10.1186/1471-2407-10-238
keywords:
Resveratrol
Colon Cancer Cell
Human Colon Cancer Cell
Suppress Cell Proliferation
Resveratrol Treatment
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig6_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig7_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig8_HTML.jpg
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:10
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Jairam Vanamala
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Lavanya Reddivari
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
type:Person
name:Sridhar Radhakrishnan
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
type:Person
name:Chris Tarver
affiliation:
name:Texas A&M University, College Station
address:
name:Institute for Obesity Research and Program Evaluation, Texas A&M University, College Station, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways
description:Obesity is a global phenomenon and is associated with various types of cancer, including colon cancer. There is a growing interest for safe and effective bioactive compounds that suppress the risk for obesity-promoted colon cancer. Resveratrol (trans-3, 4', 5,-trihydroxystilbene), a stilbenoid found in the skin of red grapes and peanuts suppresses many types of cancers by regulating cell proliferation and apoptosis through a variety of mechanisms, however, resveratrol effects on obesity-promoted colon cancer are not clearly established. We investigated the anti-proliferative effects of resveratrol on HT-29 and SW480 human colon cancer cells in the presence and absence of insulin like growth factor-1 (IGF-1; elevated during obesity) and elucidated the mechanisms of action using IGF-1R siRNA in HT-29 cells which represents advanced colon carcinogenesis. Resveratrol (100-150 ΞΌM) exhibited anti-proliferative properties in HT-29 cells even after IGF-1 exposure by arresting G0/G1-S phase cell cycle progression through p27 stimulation and cyclin D1 suppression. Treatment with resveratrol suppressed IGF-1R protein levels and concurrently attenuated the downstream Akt/Wnt signaling pathways that play a critical role in cell proliferation. Targeted suppression of IGF-1R using IGF-1R siRNA also affected these signaling pathways in a similar manner. Resveratrol treatment induced apoptosis by activating tumor suppressor p53 protein, whereas IGF-1R siRNA treatment did not affect apoptosis. Our data suggests that resveratrol not only suppresses cell proliferation by inhibiting IGF-1R and its downstream signaling pathways similar to that of IGF-1R siRNA but also enhances apoptosis via activation of the p53 pathway. For the first time, we report that resveratrol suppresses colon cancer cell proliferation and elevates apoptosis even in the presence of IGF-1 via suppression of IGF-1R/Akt/Wnt signaling pathways and activation of p53, suggesting its potential role as a chemotherapeutic agent.
datePublished:2010-05-26T00:00:00Z
dateModified:2010-05-26T00:00:00Z
pageStart:1
pageEnd:14
license:http://creativecommons.org/licenses/by/2.0
sameAs:https://doi.org/10.1186/1471-2407-10-238
keywords:
Resveratrol
Colon Cancer Cell
Human Colon Cancer Cell
Suppress Cell Proliferation
Resveratrol Treatment
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig6_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig7_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-238/MediaObjects/12885_2009_Article_2037_Fig8_HTML.jpg
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:10
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Jairam Vanamala
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Lavanya Reddivari
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
type:Person
name:Sridhar Radhakrishnan
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
type:Person
name:Chris Tarver
affiliation:
name:Texas A&M University, College Station
address:
name:Institute for Obesity Research and Program Evaluation, Texas A&M University, College Station, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:BMC Cancer
issn:
1471-2407
volumeNumber:10
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
name:Texas A&M University, College Station
address:
name:Institute for Obesity Research and Program Evaluation, Texas A&M University, College Station, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Jairam Vanamala
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Lavanya Reddivari
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
name:Sridhar Radhakrishnan
affiliation:
name:226 Gifford Building, Colorado State University
address:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
type:PostalAddress
type:Organization
name:Chris Tarver
affiliation:
name:Texas A&M University, College Station
address:
name:Institute for Obesity Research and Program Evaluation, Texas A&M University, College Station, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
name:Department of Food Science and Human Nutrition, 226 Gifford Building, Colorado State University, Fort Collins, USA
name:Institute for Obesity Research and Program Evaluation, Texas A&M University, College Station, USA
External Links {π}(10)
- How much profit is https://submission.nature.com/new-submission/12885/3 making per month?
- How much revenue does https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-10-238/12885_2009_2037_ReviewerReport_V1_R1.pdf bring in?
- What's the revenue for https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-10-238/12885_2009_2037_AuthorComment_V2.pdf?
- What's the income generated by https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-10-238/12885_2009_2037_ReviewerReport_V3_R1.pdf each month?
- https://static-content.springer.com/openpeerreview/art%3A10.1186%2F1471-2407-10-238/12885_2009_2037_AuthorComment_V4.pdf's revenue stream
- How much does https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022 gross monthly?
- https://biomedcentral.typeform.com/to/VLXboo income
- http://www.weibo.com/biomedcentral income
- Check the income stats for https://www.springernature.com/ccpa
- Earnings of https://www.springernature.com
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {π¦}
- Crossref